Biocon Chief Complains Of India Trial Delays Forcing Moves Abroad
This article was originally published in PharmAsia News
Executive Summary
The head of Biocon is threatening to conduct more of its clinical trials in other countries despite the expense, complaining of increasingly longer delays in India's approval process.